Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
REGEN Capital is an equity-based investment firm founded to support early-stage companies in frontier technologies. Established in Toronto, Canada, the firm focuses on various sectors within the healthcare industry, including biotechnology, financial technology, artificial intelligence, quantum computing, diagnostics, healthcare services, healthcare IT, and real estate. The firm has a strong commitment to driving advancements in these critical sectors through strategic investments.
Currently, REGEN Capital operates with a team of four professionals, including a Managing Director, a Director, an Analyst, and an Associate. The firm leads investment rounds with initial check sizes ranging from $50,000 to $250,000, and emphasizes close partnerships with its portfolio companies. Notable milestones include the founding of the Canadian Centre for Regenerative Therapy (CCRT), recognized as the first private cell therapy center in Canada, and the successful investment in Freyja Therapeutics, a clinical-stage company focused on umbilical cord stem cells.
REGEN Capital invests in early-stage companies across North America, specifically targeting pre-seed to early-stage ventures. The firm typically leads investments with initial check sizes ranging from $50,000 to $250,000. Their investment strategy emphasizes hands-on involvement, with a preference for being on the board of directors to assist in strategic decision-making. This approach allows them to provide ongoing support through follow-up rounds and operational guidance.
The firm is particularly focused on frontier technologies within the healthcare sector, which includes biotechnology, fintech, artificial intelligence, quantum computing, diagnostics, healthcare services, and healthcare IT. REGEN Capital seeks to partner with founders who demonstrate a strong vision and commitment to innovation, aiming to drive advancements in these critical areas.
REGEN Capital's portfolio includes several notable companies that exemplify their focus on healthcare and frontier technologies:
These companies highlight REGEN Capital's commitment to investing in innovative solutions that address pressing healthcare challenges.
Riam Shammaa: Managing Director at REGEN Capital, Riam has extensive experience in venture capital and a strong background in healthcare investments.
Jennifer Torres: Director at REGEN Capital, Jennifer brings expertise in operational support and strategic guidance for portfolio companies.
Vansh Arora: Analyst at REGEN Capital, Vansh focuses on market research and analysis to identify promising investment opportunities.
Esteena Javier: Associate at REGEN Capital, Esteena supports the investment team in due diligence and portfolio management.
To pitch to REGEN Capital, founders should reach out via email, providing a detailed business plan and financial projections. Including information about the team, market opportunity, and competitive landscape is essential. The firm prefers to receive pitches through direct email communication rather than through online portals.
Response times may vary, but founders can generally expect to hear back within a few weeks. A warm introduction can enhance the likelihood of a favorable response, so leveraging mutual connections is advisable.
As of March 2023, REGEN Capital has been actively involved in the healthcare innovation space, with notable portfolio companies such as Freyja Therapeutics and the Canadian Centre for Regenerative Therapy. The firm emphasizes ongoing support through follow-up rounds and strategic decision-making.
Recent activities include continued investment in healthcare technologies and maintaining close partnerships with their portfolio companies to drive growth and innovation.
What are REGEN Capital's investment criteria?
REGEN Capital focuses on early-stage companies in frontier technologies, particularly within the healthcare sector. They typically invest in pre-seed to early-stage ventures, leading rounds with check sizes ranging from $50,000 to $250,000.
How can founders apply or pitch to REGEN Capital?
Founders can reach out via email to express interest in pitching their startup. It is advisable to include a detailed business plan and financial projections in the initial communication.
What makes REGEN Capital different from other investors?
REGEN Capital emphasizes hands-on involvement with portfolio companies, often taking board positions to provide strategic guidance and operational support. This approach helps startups navigate challenges and scale effectively.
What is REGEN Capital's geographic focus?
The firm primarily invests in early-stage companies across North America, ensuring they can provide localized support and resources to their portfolio companies.
What is REGEN Capital's post-investment involvement like?
REGEN Capital maintains close relationships with its portfolio companies, offering ongoing operational support and strategic guidance. They are committed to assisting in follow-up rounds and decision-making processes.
What is the typical check size for investments?
REGEN Capital typically invests between $50,000 and $250,000 in their portfolio companies, depending on the specific needs and potential of the startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.